Video | Webinar: Introduction to Geron
- Global Mpn Scientific Foundation
- 6 days ago
- 1 min read
The Global MPN Scientific Foundation has released the video of the webinar “Introduction to Geron”, held on October 1st, 2025, featuring Geron, a biopharmaceutical company based in the United States currently focused on research and clinical development in Myeloproliferative Neoplasms (MPNs) and related hematologic conditions.
During the session, Christian Dimaano, Vice President and Head of Medical Affairs at Geron, presented the company’s scientific approach, its vision for advancing research, and the potential strategies being explored to address the needs of people living with MPNs.
Among these ongoing investigations, imetelstat (CT), a compound in clinical development, could represent a possible therapeutic approach for patients with MPNs in the future. REGISTER FOR THE SECOND WEBINAR ABOUT THIS CLINICAL DEVELOPMENT: https://www.gmpnsf.org/post/webinar-what-is-imetelstat
The webinar included simultaneous English–Spanish interpretation, ensuring that both patients and healthcare professionals could access the information and better understand the context of current MPN research.
The recording is now available. Watch now!
A new video, offering a closer look at Geron’s research and clinical studies, will be released soon on the GMPNSF website and social media channels.
The Global MPN Scientific Foundation wishes to thank Christian Dimaano and the Geron team for their participation and contribution to this educational initiative.